217 related articles for article (PubMed ID: 26503331)
21. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
22. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
23. PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
Scheffler M; Bos M; Gardizi M; König K; Michels S; Fassunke J; Heydt C; Künstlinger H; Ihle M; Ueckeroth F; Albus K; Serke M; Gerigk U; Schulte W; Töpelt K; Nogova L; Zander T; Engel-Riedel W; Stoelben E; Ko YD; Randerath W; Kaminsky B; Panse J; Becker C; Hellmich M; Merkelbach-Bruse S; Heukamp LC; Büttner R; Wolf J
Oncotarget; 2015 Jan; 6(2):1315-26. PubMed ID: 25473901
[TBL] [Abstract][Full Text] [Related]
24. Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue.
Gottschling S; Jauch A; Kuner R; Herpel E; Mueller-Decker K; Schnabel PA; Xu EC; Muley T; Sültmann H; Bender C; Granzow M; Efferth T; Hoffmann H; Dienemann H; Herth FJ; Meister M
Lung Cancer; 2012 Jan; 75(1):45-57. PubMed ID: 21684623
[TBL] [Abstract][Full Text] [Related]
25. New developments in the treatment of squamous cell lung cancer.
Filipits M
Curr Opin Oncol; 2014 Mar; 26(2):152-8. PubMed ID: 24441504
[TBL] [Abstract][Full Text] [Related]
26. Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype.
Krishnamurthy K; Lindsey AM; Estrada CA; Martinez CC; Cusnir M; Schwartz M; Sriganeshan V; Poppiti R
Cancer Treat Res Commun; 2020; 25():100238. PubMed ID: 33260028
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.
Xiong D; Li G; Li K; Xu Q; Pan Z; Ding F; Vedell P; Liu P; Cui P; Hua X; Jiang H; Yin Y; Zhu Z; Li X; Zhang B; Ma D; Wang Y; You M
Carcinogenesis; 2012 Sep; 33(9):1797-805. PubMed ID: 22696596
[TBL] [Abstract][Full Text] [Related]
28. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome sequencing analysis identifies a distinctive mutational spectrum in an arsenic-related lung tumor.
Martinez VD; Thu KL; Vucic EA; Hubaux R; Adonis M; Gil L; MacAulay C; Lam S; Lam WL
J Thorac Oncol; 2013 Nov; 8(11):1451-5. PubMed ID: 24128716
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
[TBL] [Abstract][Full Text] [Related]
31. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
[TBL] [Abstract][Full Text] [Related]
32. Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.
Guo JH; Ma YS; Lin JW; Jiang GX; He J; Lu HM; Wu W; Diao X; Fan QY; Wu CY; Liu JB; Fu D; Hou LK
Br J Cancer; 2023 Aug; 129(2):366-373. PubMed ID: 37179440
[TBL] [Abstract][Full Text] [Related]
33. Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.
Wang Z; Shen Z; Li Z; Duan J; Fu S; Liu Z; Bai H; Zhang Z; Zhao J; Wang X; Wang J
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9990-5. PubMed ID: 26216950
[TBL] [Abstract][Full Text] [Related]
34. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
[TBL] [Abstract][Full Text] [Related]
35. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
36. Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.
Yin S; Yang J; Lin B; Deng W; Zhang Y; Yi X; Shi Y; Tao Y; Cai J; Wu CI; Zhao G; Hurst LD; Zhang J; Hu L; Kong X
Sci Rep; 2014 Aug; 4():6036. PubMed ID: 25112956
[TBL] [Abstract][Full Text] [Related]
37. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
38. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
Andjelkovic T; Bankovic J; Stojsic J; Milinkovic V; Podolski-Renic A; Ruzdijic S; Tanic N
Transl Res; 2011 Jan; 157(1):19-28. PubMed ID: 21146147
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
[TBL] [Abstract][Full Text] [Related]
40. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]